Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Johannes Lorscheider, Vilija G. Jokubaitis, Tim Spelman, Guillermo Izquierdo, Alessandra Lugaresi, Eva Havrdova, Dana Horakova, Maria Trojano, Pierre Duquette, Marc Girard, Alexandre Prat, Francois Grand'Maison, Pierre Grammond, Eugenio Pucci, Cavit Boz, Patrizia Sola, Diana Ferraro, Daniele Spitaleri, Jeanette Lechner-Scott, Murat TerziVincent Van Pesch, Gerardo Iuliano, Roberto Bergamaschi, Cristina Ramo-Tello, Franco Granella, Celia Oreja-Guevara, Helmut Butzkueven, MSBase Study Grp, Raymond Hupperts, Tomas Kalincik*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1050-1059
Number of pages10
JournalNeurology
Volume89
Issue number10
DOIs
Publication statusPublished - 5 Sep 2017

Keywords

  • REMITTING MULTIPLE-SCLEROSIS
  • DOUBLE-BLIND
  • GLATIRAMER ACETATE
  • TREATMENT TRIALS
  • MS
  • MULTICENTER
  • INTERFERON-BETA-1A
  • FINGOLIMOD
  • SWITCH

Cite this